Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Pear Therapeutics
3233
Pear Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need.
Suggest edits
Type
B2c
Founded
2013
Raised
$234M
Follow us
Also headquartered in Boston
General Electric
DraftKings
Sophia
Bain Capital
TA Associates
Wikibon
State Street
DataRobot
Zipcar
Battery Ventures
Companies in the same industry
Biomoti
TapImmune
Aspyrian Therapeutics
Blueberry Therapeutics Ltd
ImStar Therapeutics
Acticor Biotech
Tioma Therapeutics
Proclara Biosciences
Oncorus
ELSALYS BIOTECH
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Latest funding
Show all
$80,000,000
Venture capital (Series D) - 2020
Temasek Holdings
Pilot House Ventures
Novartis
+7
$64,000,000
Venture capital (Series C) - 2019
Temasek Holdings
Novartis
EDBI
+9
Team Size
10+
Employees
I work here
Location
Boston
,
United States
Headquarters
Explore Boston
$80,000,000
Venture capital (Series D)
MedCity News
,
Pulse 2.0
Pear Therapeutics raises $80M in push for reimbursement
the home of AI info
Pear Therapeutics Expands Pipeline with Machine Learning, Digital Therapeutic and Digital ...
$64,000,000
Venture capital (Series C)
PE HUB
Pear Therapeutics locks in $64 mln Series C
$50,000,000
Venture capital (Series B)
PE HUB
| PEAR Therapeutics scores $50 mln Series B
$20,000,000
Venture capital
VentureWire
,
FinSMEs
The Daily Startup: Pear Therapeutics Aims for Digital Substance-Abuse Treatment
Funding
$20,000,000
Venture capital (Series UNDISCLOSED)
PRWeb
Digital Therapeutics Pioneer Pear Therapeutics Raises $20M
